Related Experiment Videos
Evidence for several cell populations in human thyroid with distinct glycosphingolipid patterns
B Bouchon1, J Portoukalian, A M Madec
1INSERM U.218, Centre Léon Bérard, Lyon, France.
Biochimica Et Biophysica Acta
|January 23, 1990
Summary
Thyroid cells (thyrocytes) and accessory cells have distinct glycolipid profiles. This research identifies unique neutral glycosphingolipids in thyrocytes, differentiating them from other thyroid cell populations.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Thyrocytes are the primary functional cells of the human thyroid gland.
- Understanding cellular composition requires detailed analysis of molecular components like glycosphingolipids.
- Previous research has not fully elucidated the distinct glycolipid profiles of different thyroid cell populations.
Purpose of the Study:
- To isolate and analyze the glycosphingolipid content of human thyrocytes.
- To compare the glycolipid profiles of isolated thyrocytes with those of the whole thyroid gland.
- To identify distinct cellular populations within the thyroid based on their glycolipid patterns.
Main Methods:
- Isolation of functional thyrocytes from human thyroid tissue.
- Enzymatic digestion and fractionation of the thyroid gland.
- Analysis of ganglioside and neutral glycolipid content in different tissue fractions and isolated cells using chromatographic techniques.
Main Results:
- Ganglioside content (GM3 and Gd3 as major components) showed no significant difference across fractions.
- Neutral glycolipid analysis revealed distinct patterns between isolated thyrocytes and whole thyroid tissue.
- Membranous material from proteinase-treated thyroid showed a unique monohexosylceramide pattern compared to thyrocytes.
Conclusions:
- Human thyroid tissue contains at least two distinct cellular populations with differing glycolipid profiles.
- Accessory cells appear to contain the majority of thyroid glycolipids.
- Thyrocytes are characterized by phytosphingosine-containing glucosylceramide as their major neutral glycosphingolipid.